Evkeeza

Active Ingredient(s): Evinacumab-dgnb
FDA Approved: * February 11, 2021
Pharm Company: * REGENERON PHARMACEUTICALS
Category: Cholesterol

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Evkeeza Overview

Evinacumab, sold under the brand name Evkeeza, is a monoclonal antibody medication for the treatment of homozygous familial hypercholesterolemia (HoFH).[1][2] Common side effects include nasopharyngitis (cold), influenza-like illness, dizziness, rhinorrhea (runny nose), and nausea. Serious hypersensitivity (allergic) reactions have occurred in the Evkeeza clinical trials.[2] Evinacumab binds to the angiopoietin-like protein 3 (ANGPTL3).[...

Read more Evkeeza Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Evinacumab

Recent Evkeeza Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Evinacumab-dgnb
  • Solution: 1200mg/8ml, 345mg/2.3ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Evkeeza: (2 results)

Sorted by National Drug Code
  • 61755-010 Evkeeza 150 mg/ml Intravenous Injection, Solution, Concentrate by Regeneron Pharmaceuticals, Inc.
  • 61755-013 Evkeeza 150 mg/ml Intravenous Injection, Solution, Concentrate by Regeneron Pharmaceuticals, Inc.

Other drugs which contain Evinacumab-dgnb or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 20 April 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA